Book a demoStart a pilot

Blog / Post

Blog

Your safety database isn’t the problem: the work around it is

Before you replace your safety database, look at where the manual effort really sits, and whether intelligence can be added around the system you already have.

vGenix Ai team·5 min read·November 2026

When case processing becomes slow, expensive or hard to scale, the safety database often gets the blame. Replacing it can feel like the obvious fix. But a database migration is one of the biggest projects a safety organisation can take on: data must be migrated and reconciled, the new system validated, interfaces rebuilt, people retrained and submissions kept running throughout.

Before you go down that road, it is worth asking a different question. Is the problem the database, or the work that happens around it?

Where the manual effort actually sits

A safety database is a system of record. It stores cases, applies its business rules, and produces regulatory output in the ICH E2B (R3) format. What it typically does not do is read an email, interpret a scanned form, decide whether a report is valid, spot a likely duplicate or propose the right MedDRA term. That work happens before the case reaches the database, and much of it is done by hand.

Your safetydatabaseArgus · ARISg · Vault SafetyBEFORE THE DATABASEIntake from every channelValidity and duplicate checksData extraction from documentsCoding suggestionsAFTER THE DATABASEQuality checksSubmission and acknowledgementsPartner reconciliationLiterature and signal inputsMuch of the manual effort sits in the work around the database, not inside it.
Where intelligence can be added without replacing your system of record. Illustrative.

The CIOMS Working Group XIV report on AI in pharmacovigilance (December 2025) lists where AI is already being applied in case processing: duplicate detection, coding of adverse events and products, extraction of information from narratives, and triage of incoming reports for human review. Almost all of these sit around the database, not inside it.

Replace or augment?

QuestionReplacing the databaseAdding intelligence around it
What changesSystem of record, interfaces, reports, processesIntake, preparation and checks; the database stays
Data migrationFull migration and reconciliation of historical casesNone
Validation scopeThe whole new systemThe new components and their interfaces
Disruption to submissionsCut-over has to be planned around live reportingCan run alongside the current process first
Where the benefit landsDepends on whether the new database removes the manual workDirectly on the manual steps
How you can startUsually all at onceOne process or one source at a time

When replacement really is the answer

Sometimes it is. If your database is out of support, cannot produce the regulatory formats you need, cannot meet your security or data residency requirements, or is the source of persistent data-quality problems, replacing it may be right. Even then, the work around the database still has to be solved, so it pays to understand it first.

How augmentation works in practice

  • Intake. Reports arrive from email, portals, partners and literature, in any format. They are read, classified and checked for the four minimum criteria and for duplicates.
  • Preparation. Case data is extracted and structured, each value linked to its source, and coding is suggested using your conventions.
  • Hand-over. The prepared case enters your existing safety database through its standard interfaces, for review and processing as today.
  • Checks after entry. Quality checks, deadline tracking, submission status and partner reconciliation run alongside.

Your reviewers keep working in the system they know, your validated database stays validated, and the manual effort moves out of the process.

A phased path

Because augmentation leaves the database in place, it can start small and grow, with each phase validated and measured before the next.

PHASE 1IntakeRead and classifyevery reportPHASE 2PreparationExtract data,suggest codingPHASE 3ChecksQuality, deadlines,reconciliationPHASE 4InsightLiterature andsignal inputsYour safety database stays in place throughout; each phase is validated and measured before the next.
A phased roadmap for adding intelligence around an existing safety database. Illustrative.

Each phase runs alongside the current process at first, so the team can compare results on the same cases before switching over. If a phase does not deliver against its baseline, you have learned that cheaply, without touching your system of record.

What to measure

  • Data-entry time per case before and after preparation is automated.
  • Time from receipt to case creation, which protects the regulatory clock.
  • Duplicate cases found after entry, which should fall as checks move upstream.
  • QC findings per 100 cases, to confirm that speed has not cost quality.

Questions to ask before you decide

  • Which steps take the most time today, and how many of them happen inside the database?
  • What would a migration cost in time, validation effort and risk to submissions?
  • Could intelligence be added to the steps around the database first, and measured?
  • Does your database have the interfaces needed to accept prepared cases?
Keep your platform, add the intelligence: Intelligence as a Service (IntaaS) brings Pharmacovigilance, Document, Regulatory and Compliance Intelligence to the systems you already run, through secure APIs. See the integrations we support.

Sources

  1. CIOMS Working Group XIV, Artificial Intelligence in Pharmacovigilance (report published 4 December 2025)
  2. EMA, Guideline on good pharmacovigilance practices (GVP) Module VI, Rev 2
Keep reading

More from the blog

Blog

Audit trails in pharmacovigilance: what inspectors look for, and how AI changes the picture

Read →
Blog

The hidden cost of a pharmacovigilance case: where the hours really go

Read →
Blog

Inspection-ready every day: ending the scramble before a pharmacovigilance inspection

Read →
Next step

Intelligent safety should be one connected operation

Automate the work. Keep the decisions with your experts. Keep the evidence traceable. See it on your own data in six weeks.

Recommended

6-week pilot on literature monitoring

  • Baselines agreed up front
  • Configured to your SOPs
  • Measured on your own data
  • Validation evidence from day one
Start your pilot